Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications

Annals of Diagnostic Pathology

Volumn 21, Issue , 2016, Pages 7-11

  Kurtis, Boaz ^a   Zhuge, Jian ^a   Ojaimi, Caroline ^a   Ye, Fei ^a   Cai, Dongming ^a   Zhang, David ^a   Fallon, John T ^a   Zhong, Minghao ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Diagnosis; TERT promoter mutation; Urine; Urothelial carcinoma

Indexed keywords

CYSTEINE; TELOMERASE REVERSE TRANSCRIPTASE; THREONINE; TELOMERASE; TERT PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLADDER INJURY; BLOOD SAMPLING; CANCER GRADING; CANCER PATIENT; CONTROLLED STUDY; CYSTECTOMY; CYSTITIS; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVERTED PAPILLOMA; KIDNEY ADENOMA; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHROGENIC ADENOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SANGER SEQUENCING; SEQUENCE ANALYSIS; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR RECURRENCE; URETHRA; URINALYSIS; URINARY TRACT; UROTHELIUM; WILD TYPE; BLOOD; CARCINOMA, TRANSITIONAL CELL; DNA SEQUENCE; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; URINARY BLADDER NEOPLASMS; URINE; UROLOGIC NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TELOMERASE; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84962835857     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2015.12.002     Document Type: Article

References (28)

1. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
2. S. Horn, A. Figl, P.S. Rachakonda, C. Fischer, A. Sucker, A. Gast, and et al. TERT promoter mutations in familial and sporadic melanoma Science 339 6122 2013 959 961
3. F.W. Huang, E. Hodis, M.J. Xu, G.V. Kryukov, L. Chin, and L.A. Garraway Highly recurrent TERT promoter mutations in human melanoma Science 339 6122 2013 957 959
4. P.J. Killela, Z.J. Reitman, Y. Jiao, C. Bettegowda, N. Agrawal, L.A. Diaz Jr., and et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal Proc Natl Acad Sci U S A 110 15 2013 6021 6026
5. J. Vinagre, A. Almeida, H. Populo, R. Batista, J. Lyra, V. Pinto, and et al. Frequency of TERT promoter mutations in human cancers Nat Commun 4 2013 2185
6. Y. Allory, W. Beukers, A. Sagrera, M. Flandez, M. Marques, M. Marquez, and et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome Eur Urol 65 2 2014 360 366
7. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 1 2014 9 29
8. D. Castellano, J. Carles, E. Esteban, J.M. Trigo, M.A. Climent, J.P. Maroto, and et al. Recommendations for the optimal management of early and advanced urothelial carcinoma Cancer Treat Rev 38 5 2012 431 441
9. J.A. Smith Jr. Endoscopic applications of laser energy Urol Clin North Am 13 3 1986 405 419
10. J.A. Smith Jr., R.F. Labasky, A.T. Cockett, J.A. Fracchia, J.E. Montie, and R.G. Rowland Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association J Urol 162 5 1999 1697 1701
11. M.F. Tanaka, and G. Sonpavde Diagnosis and management of urothelial carcinoma of the bladder Postgrad Med 123 3 2011 43 55
12. G.J. Netto Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol 9 1 2012 41 51
13. C.D. Hurst, F.M. Platt, and M.A. Knowles Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine Eur Urol 65 2 2014 367 369
14. I. Kinde, E. Munari, S.F. Faraj, R.H. Hruban, M. Schoenberg, T. Bivalacqua, and et al. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine Cancer Res 73 24 2013 7162 7167
15. X. Liu, G. Wu, Y. Shan, C. Hartmann, A. von Deimling, and M. Xing Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma Cell Cycle 12 10 2013 1637 1638
16. D.S. Huang, Z. Wang, X.J. He, B.H. Diplas, R. Yang, P.J. Killela, and et al. Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation Eur J Cancer 51 8 2015 969 976
17. I. Hosen, P.S. Rachakonda, B. Heidenreich, P.J. de Verdier, C. Ryk, G. Steineck, and et al. Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer Int J Cancer 137 7 2015 1621 1629
18. A. Mohammed, Z. Khan, I. Zamora, and A. Bhatti Biological markers in the diagnosis of recurrent bladder cancer: an overview Expert Rev Mol Diagn 8 1 2008 63 72
19. S.A. Thiryayi, and D.N. Rana Urine cytopathology: challenges, pitfalls, and mimics Diagn Cytopathol 40 11 2012 1019 1034
20. B. Tetu Diagnosis of urothelial carcinoma from urine Mod Pathol 22 Suppl. 2 2009 S53 S59
21. S.S. Garfield, M.B. Gavaghan, S.O. Armstrong, and J.S. Jones The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation Can J Urol 20 2 2013 6682 6689
22. M.L. Hemani, and C.L. Bennett The excessive cost of early stage bladder cancer care: are providers really to blame? Cancer 116 15 2010 3530 3532
23. E. Xylinas, L.A. Kluth, M. Rieken, P.I. Karakiewicz, Y. Lotan, and S.F. Shariat Urine markers for detection and surveillance of bladder cancer Urol Oncol 32 3 2014 222 229
24. N.P. Munro, and M.A. Knowles Fibroblast growth factors and their receptors in transitional cell carcinoma J Urol 169 2 2003 675 682
25. G.J. Netto Molecular genetics and genomics progress in urothelial bladder cancer Semin Diagn Pathol 30 4 2013 313 320
26. M. Zhong, W. Tian, J. Zhuge, X. Zheng, T. Huang, D. Cai, and et al. Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation Am J Surg Pathol 39 1 2015 127 131
27. X. Zheng, J. Zhuge, S.M. Bezerra, S.F. Faraj, E. Munari, J.T. Fallon III, and et al. High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins J Hematol Oncol 7 2014 47
28. K. Wang, T. Liu, L. Liu, J. Liu, C. Liu, C. Wang, and et al. TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas Oncotarget 5 7 2014 1829 1836